Background: Intestinal manometry is the current standard for direct evaluation of
| INTRODUCTION
Intestinal manometry remains the current standard for recognition of gastrointestinal motility disorders, although other methods such as transit scintigraphy, functional magnetic resonance, and endoluminal image motility analysis are further expanding diagnostic capabilities and general understanding of these conditions. [1] [2] [3] [4] [5] Beyond the classic clinical picture of chronic intestinal pseudo-obstruction (CIPO), characterized by recurrent episodes or sustained radiological findings mimicking mechanical obstruction, 6 intestinal manometry has documented an additional group of patients suffering from disabling abdominal pain and other severe abdominal symptoms in the absence of clinical signs of mechanical bowel obstruction. This group of patients with abnormal contractile activity has been named enteric dysmotility (ED). 7, 8 The clinical presentation of ED corresponds to that of severe functional gastrointestinal disorders (SFGID). 9 Both CIPO and ED are associated with enteric neuromuscular abnormalities shown by histological and immunopathological analysis of full-thickness biopsies of the small bowel usually obtained via laparoscopy.
10,11
Neither intestinal manometry nor small bowel neuromuscular pathology are fully standardized diagnostic methods and both technical details and criteria for interpretation vary from center to center.
12,13
To some extent, this uncertain status results from the relative rarity of patients with a clinical expression of gastrointestinal dysmotility severe enough to justify invasive diagnostic procedures such as intestinal manometry and full-thickness biopsy. It also derives from the relative sophistication and complexity of both technologies, manometry and neuromuscular pathology, that confines them to a relatively small cluster of university medical centers around the world. Moreover, only a handful of published studies over the last 15-20 years have attempted to correlate intestinal dysmotility patterns, recorded manometrically, with morphological changes subsequently investigated in full-thickness bowel biopsies. 10, [14] [15] [16] [17] The aim of the present study was to prospectively compare small bowel manometric abnormalities with subsequent histopathological findings in full-thickness intestinal biopsies. The former were evaluated by consensus, among an international group of academic gastroenterologists routinely applying intestinal manometry for diagnostic purposes. Enteric neuromuscular abnormalities were assessed by a group of experienced gut neuromuscular pathologists at a single medical center. The comparison between manometric findings and neuromuscular pathological findings was performed on a group of patients presenting with severe and chronic clinical manifestations of gastrointestinal dysmotility. Our hypothesis was that abnormal manometric patterns would predict histopathological abnormalities found on subsequently obtained intestinal tissue specimens. and subsequently a full-thickness biopsy were included in the study.
| MATERIAL AND METHODS

| Patients
Full-thickness intestinal biopsy was obtained only in patients with a clinical diagnosis of an idiopathic severe intestinal motility disorder.
Therefore, high severity was the enforced selection criterion that delimited the consecutive series of patients included in this study.
Patients with motility disorders secondary to infectious, neurological, metabolic, systemic-autoimmune and paraneoplastic conditions were 
| Intestinal manometry
All study patients underwent intestinal manometry according to a standard stationary procedure. After an overnight fast,
Key Points
• Intestinal manometry and/or histopathology are the current standard for the diagnosis of severe small bowel dysmotility disorders. However, the degree of correlation between the two methods is unknown.
• Results of this study indicate that more than two-thirds of these severe clinical cases with abnormal manometry also have abnormal histopathology underlying gut dysmotility.
• Nonetheless, we detected no correlation between the specific manometric patterns and histopathological findings.
a manometric tube (9012X1106 Special Manometric Catheter;
Medtronic, Skovlunde, Denmark) was orally introduced into the je- Table S1 ). The occlusive pattern was considered indicative of intestinal neuropathy in the absence of mechanical obstruction. CD4 and CD8 (markers of T lymphocyte subsets, that is, "helper"
and "suppressor," respectively). Finally, an anti-tryptase antibody was used to detect mast cells (all antibodies are listed in the Table S2 ). The immunohistochemical techniques used in this study have been performed according to standardized and widely validated protocols. 19 Four histopathological patterns, identified according to the London classification, were recognized. 20 Main findings for each of these patterns are detailed:
• Apparently normal: no detectable changes in the neuromuscular layer using conventional histochemical staining and immunohistochemistry;
• Myopathy: muscular degeneration with cell swelling, vacuolization or atrophy; fibrotic replacement of smooth muscle (detectable by conventional staining, such as H&E, and immunohistochemical approaches, for example, α-SMA immunoreactivity abnormalities);
• Neuropathy: overt ganglionic abnormalities as identified by traditional tinctorial staining (H&E) and immunohistochemical approaches (pan-neuronal markers); altered neuronal survival was identified by assessing BCL-2 expression in perikarya and nerve fibers (a feature which has been already associated with increased neuronal apoptosis); 
| Statistical analysis
Statistical analysis was performed using the SPSS 12.0 for Windows statistical package (SPSS Inc., Chicago, IL, USA). Distribution of abnormalities between groups was evaluated by the chi-square test.
Predictive values (with 95% exact confidence intervals) were calculated as the probability of abnormal histopathology when manometry was abnormal (positive predictive value) and of normal histopathology when manometry was normal (negative predictive value). Concordance between the outcomes of manometry and histology was evaluated with Cohen's Kappa (κ) agreement analysis. Differences were considered significant at a P < .05.
| RESULTS
| Clinical features
Patients were classified into two categories depending on the pre- 
| Manometric study
Manometry recordings obtained from the 38 patients included in the study were reviewed by each of the expert investigators. Investigators were instructed to read each patient manometric tracing according to the strict criteria described in Table S1 . A diagnostic consensus was obtained in 35 of the 38 patients (92% agreement). These 35 patients were included in the subsequent comparison manometry vs histopathology results.
We found no apparent correlation between manometric features and clinical presentation. As shown by Table 1 , there was a similar proportion of patients with a neuropathic or an undetermined manometric pattern in both the CIPO and SFGID clinical groups. The myopathic or occlusive patterns were only observed in patients with CIPO. It should be noted that all 3 patients who showed a myopathic pattern on manometry had dilated small bowel loops on imaging studies.
| Histopathological findings
Ten of the study patients (7 females; age range: 24-61) showed an apparently normal small bowel histopathology. Another group had an inflammatory neuromyopathy with a predominantly lymphocytic or eosinophilic or mast cell infiltrate in the neuromuscular layer (Figures 3 and 4) . CIPO, chronic intestinal pseudo-obstruction; SFGID, severe functional gastrointestinal disorders.
T A B L E 1 Clinical, manometric, and histopathological features in CIPO and SFGID
There were no differences in terms of pathological findings between CIPO and SFGID groups (Table 1) .
| Comparison between manometric findings and histopathological features
Among the 21 patients with a neuropathic pattern on manometry Two of the 3 patients with a myopathic motility pattern on manometry ( Figure 6 ) showed histopathological features of neuropathy and the third patient showed an inflammatory neuromyopathy.
Furthermore, all 3 patients with an occlusive manometric pattern ( Figure 7 ) also showed an inflammatory neuromyopathy at histology. 2 patients were apparently normal, 2 showed inflammatory neuromyopathy, and the remaining patient showed myopathy.
Cross-tabulation between manometric and histopathological findings is shown in Table 2 . The degree of agreement between both techniques was non-significant by Cohen's κ test (κ = 0.09, P = .541). The positive predictive value of manometry to detect abnormal histopathology was 73% (66-79), whereas the negative predictive value was 40% (12-77).
| DISCUSSION
The present study addresses a relevant clinical question, that is, what
is the value of manometric findings to predict abnormal histopathology Values indicate number of patients per subgroup. The degree of agreement between both techniques was non-significant by Cohen's κ test (κ = 0.09, P = .541).
T A B L E 2 Cross-tabulation of manometric findings and histopathological features
on a subsequent full-thickness biopsy performed in patients with a major chronic intestinal motor disorder.
The results suggest that about three quarters of patients with a definitely abnormal intestinal manometry will show an abnormal intestinal histopathology if biopsied. This observation may be particularly useful when clinicians ponder whether to biopsy a patient with a symptomatic motility disorder given the fact that full-thickness intestinal biopsy, be it performed via laparoscopy or laparotomy, is an invasive procedure with significant morbidity. On the other hand, the small number of patients with a normal manometry in our study is insufficient to either support or challenge Törnblom et al's observation that patients with or without abnormal manometry show similar histological degrees of inflammatory neuromyopathy. We recognize some weaknesses in our study. First, the small number of patients included due to the relative rarity of gut motility disorders, even at established referral centers, with a high enough degree of clinical severity and quality of life impairment to warrant invasive diagnostic procedures such as those applied in our patient cohort, could have contributed to a "limited challenge bias." Moreover, the rarity of some conditions in adulthood, for instance degenerative myopathies (4 cases in our study), could make our sample size insufficient to assert the predictive value of manometry in these small groups of patients.
Second, to standardize the manometric procedure employed in our patient cohort, we included only patients studied in one of the participating centers. We do not know whether other intestinal manometry protocols, such as 24 hour ambulatory manometry, would provide similar information or produce different outcomes. In addition, contrary to the consensus approach adopted for assessment of manometric Even accepting the above shortcomings, our data suggest that intestinal manometry helps to objectively diagnose intestinal dysmotility in patients with severe and long-standing abdominal symptoms of uncertain origin. In addition, an abnormal manometry implies a relatively high probability of subsequently finding neuromuscular histological abnormalities on full-thickness intestinal biopsies.
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